Renal Cell Cancer, Recurrent Completed Phase 2 Trials for Interferon alfa-2a (DB00034)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00059813Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerTreatment